These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 27439614)

  • 21. Over-expression of FoxM1 is associated with adverse prognosis and FLT3-ITD in acute myeloid leukemia.
    Liu LL; Zhang DH; Mao X; Zhang XH; Zhang B
    Biochem Biophys Res Commun; 2014 Mar; 446(1):280-5. PubMed ID: 24582753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Foxm1 Improves Cytotoxicity of Paclitaxel and Cisplatinum in Platinum-Resistant Ovarian Cancer.
    Westhoff GL; Chen Y; Teng NNH
    Int J Gynecol Cancer; 2017 Jun; 27(5):887-894. PubMed ID: 28498253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas.
    Lagarde P; Przybyl J; Brulard C; Pérot G; Pierron G; Delattre O; Sciot R; Wozniak A; Schöffski P; Terrier P; Neuville A; Coindre JM; Italiano A; Orbach D; Debiec-Rychter M; Chibon F
    J Clin Oncol; 2013 Feb; 31(5):608-15. PubMed ID: 23319690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma.
    Gu C; Jing X; Holman C; Sompallae R; Zhan F; Tricot G; Yang Y; Janz S
    BMC Cancer; 2018 Nov; 18(1):1152. PubMed ID: 30463534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma.
    Peng C; Zhao H; Chen W; Song Y; Wang X; Li J; Qiao Y; Wu D; Ma S; Wang X; Gao C
    Oncotarget; 2016 Oct; 7(41):66822-66834. PubMed ID: 27572315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-FLIP promotes drug resistance in non-small-cell lung cancer cells via upregulating FoxM1 expression.
    Wang WD; Shang Y; Wang C; Ni J; Wang AM; Li GJ; Su L; Chen SZ
    Acta Pharmacol Sin; 2022 Nov; 43(11):2956-2966. PubMed ID: 35422085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of metformin on FOXM1 expression and on the biological behavior of acute leukemia cell lines.
    Zhang B; Liu LL; Mao X; Zhang DH
    Mol Med Rep; 2014 Dec; 10(6):3193-8. PubMed ID: 25310131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1.
    Jiao X; Yu W; Qian J; Chen Y; Wei P; Fang W; Yu G
    BMC Cancer; 2018 May; 18(1):570. PubMed ID: 29776401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel.
    Li X; Qiu W; Liu B; Yao R; Liu S; Yao Y; Liang J
    J Transl Med; 2013 Sep; 11():204. PubMed ID: 24004449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of Forkhead Box M1 and Anticancer Effects of FOXM1 Inhibition in Epithelioid Sarcoma.
    Shibui Y; Kohashi K; Hino Y; Tamaki A; Kinoshita I; Yamamoto H; Nakashima Y; Tajiri T; Oda Y
    Lab Invest; 2024 Aug; 104(8):102093. PubMed ID: 38857782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis.
    Liang SK; Hsu CC; Song HL; Huang YC; Kuo CW; Yao X; Li CC; Yang HC; Hung YL; Chao SY; Wu SC; Tsai FR; Chen JK; Liao WN; Cheng SC; Tsou TC; Wang IC
    Oncogene; 2021 Jul; 40(30):4847-4858. PubMed ID: 34155349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of FOXM1 and related proteins in breast cancer molecular subtypes.
    Lee JJ; Lee HJ; Son BH; Kim SB; Ahn JH; Ahn SD; Cho EY; Gong G
    Int J Exp Pathol; 2016 Apr; 97(2):170-7. PubMed ID: 27277416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FOXM1 is a novel predictor of recurrence in patients with oral squamous cell carcinoma associated with an increase in epithelial‑mesenchymal transition.
    Luo YD; Ding X; Du HM; Wu YN; Li HQ; Wu HM; Zhang XM
    Mol Med Rep; 2019 May; 19(5):4101-4108. PubMed ID: 30942437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of FOXM1 is associated with metastases of nasopharyngeal carcinoma.
    Jiang L; Wang P; Chen H
    Ups J Med Sci; 2014 Nov; 119(4):324-32. PubMed ID: 25231007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy.
    Uddin S; Ahmed M; Hussain A; Abubaker J; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Jehan Z; Bavi P; Siraj AK; Al-Kuraya KS
    Am J Pathol; 2011 Feb; 178(2):537-47. PubMed ID: 21281787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
    He S; Liao B; Deng Y; Su C; Tuo J; Liu J; Yao S; Xu L
    BMC Cancer; 2017 Oct; 17(1):673. PubMed ID: 28978307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopathologic features and its prognostic significance.
    Yang DK; Son CH; Lee SK; Choi PJ; Lee KE; Roh MS
    Hum Pathol; 2009 Apr; 40(4):464-70. PubMed ID: 19121844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells.
    Zhang X; Cheng L; Minn K; Madan R; Godwin AK; Shridhar V; Chien J
    Oncotarget; 2014 Nov; 5(22):11365-80. PubMed ID: 25426548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. G3139 antisense oligonucleotide directed against antiapoptotic Bcl-2 enhances doxorubicin cytotoxicity in the FU-SY-1 synovial sarcoma cell line.
    Joyner DE; Albritton KH; Bastar JD; Randall RL
    J Orthop Res; 2006 Mar; 24(3):474-80. PubMed ID: 16450387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells.
    Lok GT; Chan DW; Liu VW; Hui WW; Leung TH; Yao KM; Ngan HY
    PLoS One; 2011; 6(8):e23790. PubMed ID: 21858223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.